Oncogenuity, Inc

Website
2 Gansevoort St Ste 9
New York, NY 10014

Oncogenuity, Inc. is a New York-based biotechnology company specializing in the development of novel oligonucleotides for the treatment of genetically driven diseases, including cancers and coronaviruses. Their groundbreaking approach involves targeting gene-silencing at the DNA level, aiming to address the root causes of genetic mutations.

What sets Oncogenuity apart is their pipeline of targeted therapeutics, which combines gene sequence data with rigorous statistical, mechanical, and molecular modeling. Their proprietary platform produces highly effective oligomers, known as ONCOlogues, capable of binding gene sequences 1,000 times more effectively than complementary native DNA. With a focus on mutations historically considered un-druggable, Oncogenuity is at the forefront of advancing innovative solutions for genetic diseases.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkNew YorkOncogenuity, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.